Healthcare & Life Sciences
Akiram Therapeutics
Swedenakiramtherapeutics.com
Akiram Therapeutics is a Healthcare & Life Sciences startup based in Sweden, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Akiram Therapeutics
Akiram Therapeutics is a company headquartered in Sweden. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Akiram Therapeutics develops targeted radioimmunotherapy treatments for metastatic solid tumors by delivering radioactive molecules directly to cancer cells to improve treatment efficacy and minimize damage to healthy tissue.
Explore Akiram Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.